Advertisement
Original article| Volume 27, ISSUE 2, P101-107, March 2005

Electroclinical characteristics of seizures—comparing Prader-Willi syndrome with Angelman syndrome

  • Pen-Jung Wang
    Correspondence
    Corresponding author. Address: Department of Pediatrics, Tzu Chi University and Medical Center, 701, Sec 3, Chung-Yang Road, Hualien, Taiwan. Tel.: +886-3-8565301; fax: +886-3-8578387
    Affiliations
    Department of Pediatrics, Tzu Chi University and Medical Center, 701, Sec 3, Chung-Yang Road, Hualien, Taiwan

    Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    Search for articles by this author
  • Jia-Woei Hou
    Affiliations
    Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan

    Department of Medical Genetics, Chang Gung Children's Hospital, Tauyang, Taiwan
    Search for articles by this author
  • Whey-Chen Sue
    Affiliations
    Department of Pediatrics, Taipei Municipal Women and Children Hospital, Taipei, Taiwan
    Search for articles by this author
  • Wang-Tso Lee
    Affiliations
    Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    Search for articles by this author

      Abstract

      Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two clinically distinct neurobehavioral syndromes that are caused by deficiency of gene expression from paternally or maternally derived homologues on chromosome 15q11–q13, respectively. Clinical and genetic heterogeneities are common in both syndromes and they are now regarded as ‘sister genetic imprinting syndromes’. This study aimed to describe and compare the electroclinical characteristics of seizures between PWS and AS, and to try to explore the possible mechanisms of epileptogenesis in these two syndromes. Fifty patients with genetically documented PWS and 18 patients with a putative diagnosis of AS were included in this study. These patients were diagnosed on the basis of characteristic physical findings and their neurobehavioral phenotype, as well as cytogenetic and molecular studies. Epileptic seizures were present in 16 of 18 patients with AS, but in only eight of 50 patients with PWS. Using electroencephalography (EEG), the most characteristic findings for AS were rhythmic 2–3 Hz delta waves of high-amplitude that were maximal over the frontal regions, and 3–4 Hz spikes and sharp wave runs posteriorly. These were never seen in PWS. Patients with AS had a much higher incidence of seizures with characteristic EEG findings, similar to those seen in mice that are deficient in a single gene (UBE3A) that displays regional brain-specific imprinting in humans and mice. In this series, cases with no detectable cytogenetic or molecular defect at the AS locus displayed similar AS phenotype, seizure severity and EEG abnormalities compared to those with such a defect. Thus, the UBE3A gene is presumed to be potentially involved in the epileptogenesis of AS. It is also possible that UBE3A and another gene located nearby, γ-aminobutyric receptorβ3 subunit, may interact in some way, and result in the severe epilepsy seen with AS. Some patients with PWS and AS share the common EEG features of persistent high-amplitude 4–6 Hz activity in recordings during sleep, and while awake. The significance of such EEG findings needs further experience to clarity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nicholls R.D.
        Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndrome: a review.
        Am J Med Genet. 1993; 46: 16-25
        • Cassidy S.B.
        • Dykens E.
        • William C.A.
        Prader-Willi and Angelman syndromes: sister imprinted disorders.
        Am J Med Genet. 2000; 97: 136-146
        • Shemer R.
        • Hershko A.Y.
        • Perk J.
        • Mosteslavsky R.
        • Tsuberi B.-Z.
        • Cedar H.
        • et al.
        The imprinting box of the Prader-Willi/Angelman syndrome domain.
        Nat. Genet. 2000; 26: 440-443
        • Prader A.
        • Lobhart A.
        • Willi H.
        Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myotonieartigen Zustand im Neugeborenenalter (In German).
        Schweiz Med Wochenschr. 1956; 86: 1260-1261
        • Butler M.G.
        Prader-Willi syndrome: current understanding of cause and diagnosis.
        Am J Med Genet. 1990; 35: 319-332
        • Holm V.A.
        • Cassidy S.B.
        • Butler M.G.
        • Hanchett J.M.
        • Greenwag L.R.
        • Whitman B.Y.
        • et al.
        Prader-Willi syndrome: consensus diagnostic criteria.
        Pediatrics. 1993; 91: 398-402
        • Angelman H.
        Puppet children: a report of three children.
        Dev Med Child Neurol. 1965; 7: 681-688
        • Williams C.A.
        • Angelman H.
        • Clayton-Smith J.
        Angelman syndromes: consensus for diagnostic criteria.
        Am J Med Genet. 1995; 56: 237-238
        • Schinzel A.
        • Niedrist D.
        Chromosome imbalances associated with epilepsy.
        Am J Med Genet. 2001; 106: 119-124
        • Hou J.W.
        • Wang P.J.
        • Wang T.R.
        Angelman syndrome assessed by neurological and molecular cytogenetic investigation.
        Pediatr Neurol. 1997; 16: 17-22
        • Hou J.W.
        • Wang T.R.
        Prader-Willi syndrome: clinical and molecular cytogenetic investigations.
        J Formos Med Assoc. 1996; 95: 474-479
        • Laan L.A.E.M.
        • Haeringen A.V.
        • Brouwer O.F.
        Angelman syndrome: a review of clinical and genetic aspects.
        Clin Neurol Neurosurg. 1999; 101: 161-170
        • Hou J.W.
        • Lee M.L.
        • Wang T.R.
        Identification of sex chromosomal abnormalities by fluorescence in situ hybridization.
        Acta Paediatr Sin. 1992; 33: 332-340
        • Kuwano A.
        • Mutirangura A.
        • Dittrich B.
        Molecular dissection of the Prader-Willi/Angelman syndrome region (15q11–q13) by YAC cloning and FISH analysis.
        Hum Mol Genet. 1992; 1: 417-425
        • Hou J.W.
        • Wang T.R.
        Cytogenetic investigations in trisomy 21 with reciprocal 4/9 translocation.
        J Formos Med Assoc. 1994; 93: 958-960
        • Dittrich B.
        • Buiting K.
        • Cross S.
        • Horsthemke B.
        Characterization of a methylation imprint in the Prader-Willi syndrome chromosome region.
        Hum Mol Genet. 1993; 2: 1995-1999
        • Nicholls R.D.
        • Saitoh S.
        • Horsthemke B.
        Imprinting in Prader-Willi and Angelman syndrome.
        Trends Genet. 1998; 14: 194-200
        • Robinson W.
        • Christian S.
        • Kuchinka B.
        • Penaherrera M.
        • Dar S.
        • Schuffenhauer S.M.
        • et al.
        Somatic segregation errors predominantly contribute to the gain or loss of a paternal chromosome leading to uniparental disomy for chromosome 15.
        Clin Genet. 2000; 57: 349-358
        • Ohta T.
        • Buiting K.
        • Kokkonen H.
        • McCandless S.
        • Heeger S.
        • Leisti H.
        • et al.
        Molecular mechanism of Angelman syndrome in two large families involved an imprinting mutation.
        Am J Hum Genet. 1999; 64: 385-396
        • Ohta T.
        • Gray T.A.
        • Rogan P.K.
        • Buiting K.
        • Gabriel J.M.
        • Saitoh S.
        • et al.
        Imprinting-mutation mechanisms in Prader-Willi syndrome.
        Am J Hum Genet. 1999; 64: 397-413
        • Kishino T.
        • Wagstaff J.
        Genomic organization of the UBE3A/E6-AP gene and related pseudogenes.
        Genomics. 1998; 47: 101-107
        • Rougeulle C.
        • Glatt H.
        • Lalande M.
        The Angelman syndrome candidate gene. UBE3A/E6-AP, is imprinted in brain.
        Nat Genet. 1997; 17: 14-15
        • Buoni S.
        • Grosso S.
        • Pucci L.
        • Fois A.
        Diagnosis of Angelman syndrome: clinical and EEG criteria.
        Brain Dev. 1999; 21: 296-302
        • Minassian B.A.
        • DeLorey T.M.
        • Olsen R.W.
        • Philippart M.
        • Bronstein Y.
        • Zang Q.
        • et al.
        Angelman syndrome: correlation between epilepsy phenotypes and genotypes.
        Ann Neurol. 1998; 43: 485-493
        • Yamada K.A.
        • Volpe J.J.
        Angelman's syndrome in infancy.
        Dev Med Child Neurol. 1990; 32: 1005-1010
        • Boyd S.G.
        • Harden A.
        • Patton M.A.
        EEG in early diagnosis of the Angelman (happy puppet) syndrome.
        Eur J Paediatr. 1998; 147: 508-513
        • DeLorey T.M.
        • Olsen R.W.
        GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.
        Epilepsy Res. 1999; 36: 123-132
        • Miura K.
        • Kishino T.
        • Li E.
        • Webber H.
        • Dikkens P.
        • Holmes G.L.
        • et al.
        Neurobehavioral and electroencephalographic abnormalities in ube3a maternal-deficient mice.
        Neurobiol Dis. 2002; 9: 149-159